In tumor cells, PKM2 prefers to exist in dimeric or monomeric forms which have reduced catalytic activity and promote lactate production rather than normal respiratory chain, enhancing anabolic synthesis of glycolytic intermediates to support cancer cell growth [25]. This evidence concerns the gene PKM and neoplasm.